Could a daily probiotic shield babies from allergies?
NCT ID NCT07490587
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a daily probiotic supplement (Bifidobacterium lactis XLTG11) can lower the chance of allergies in healthy infants under 3 years old who are at higher risk. Over 180 days, researchers will track allergy symptoms and analyze gut bacteria changes. The goal is to see if this simple intervention can support immune development and reduce allergic reactions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Bifidobacterium animalis subsp. lactis XLTG11 probiotic
What this could lead to
If it works, this could point toward a simple daily supplement to help prevent allergies in infants at high risk.
What could go wrong
This is an early phase 2 trial, so results are not yet proven. The probiotic may not reduce allergies, and individual responses can vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY CHILDREN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Sixth People's Hospital
RECRUITINGPudong, Shanghai Municipality, 201306, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universiti Sains Malaysia
NOT_YET_RECRUITINGPulau Pinang, Pulau Pinang, 11800, Malaysia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••